Literature DB >> 35687815

An Ethical Imperative to Ensure Uninterrupted HIV Care Following Therapeutic Trials: One Experience in Peru.

Katherine Garcia-Rosales1, Karin Sosa Barbaran2, Jessica Rios2, Delia Pinto-Santini1, Maria Del Rosario Leon2, Jorge A Gallardo-Cartagena3,4, John MacRae2, Mey Leon2, Javier Valencia-Huamaní2, Esmelda Montalban2, Pedro Gonzales2, Ann Duerr1,5, Javier R Lama2,5, Rachel Bender Ignacio1,5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35687815      PMCID： PMC9464051          DOI： 10.1089/apc.2022.0075

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.944


× No keyword cloud information.
  15 in total

Review 1.  Planning for posttrial access to antiretroviral treatment for research participants in developing countries.

Authors:  Seema Shah; Stacey Elmer; Christine Grady
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

2.  Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical Study.

Authors:  Javier R Lama; Rachel A Bender Ignacio; Ricardo Alfaro; Jessica Rios; Jorge Gallardo Cartagena; Rogelio Valdez; Carolyn Bain; Karin Sosa Barbarán; Manuel V Villaran; Christopher D Pilcher; Pedro Gonzales; Jorge Sanchez; Ann Duerr
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

3.  Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.

Authors:  Marta Massanella; Rachel A Bender Ignacio; Javier R Lama; Amélie Pagliuzza; Sayan Dasgupta; Ricardo Alfaro; Jessica Rios; Carmela Ganoza; Delia Pinto-Santini; Trupti Gilada; Ann Duerr; Nicolas Chomont
Journal:  Lancet Microbe       Date:  2021-03-23

4.  Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.

Authors:  Andrea L Ciaranello; Rochelle P Walensky; Paul E Sax; Yuchiao Chang; Kenneth A Freedberg; Joel S Weissman
Journal:  HIV Clin Trials       Date:  2009 Jan-Feb

5.  Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.

Authors:  N Sofaer; C Thiessen; S D Goold; J Ballou; K A Getz; G Koski; R A Krueger; J S Weissman
Journal:  J Med Ethics       Date:  2009-03       Impact factor: 2.903

6.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

7.  Post-trial access to tested interventions: the views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study.

Authors:  Christine Pace; Christine Grady; David Wendler; Judith D Bebchuk; Jorge A Tavel; Laura A McNay; Heidi P Forster; Jack Killen; Ezekiel J Emanuel
Journal:  AIDS Res Hum Retroviruses       Date:  2006-09       Impact factor: 2.205

Review 8.  Posttrial Access to Medical Interventions: Intricacies, Challenges, and Solutions.

Authors:  Harmanjit Singh; Sunil Vishwas Rao; Ashish Kumar Kakkar; Jagjit Singh; Hasitha Daina Manohar
Journal:  Int J Appl Basic Med Res       Date:  2019 Jan-Mar

9.  Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.

Authors:  Julius Kiwanuka; Jacinta Mukulu Waila; Methuselah Muhindo Kahungu; Jonathan Kitonsa; Noah Kiwanuka
Journal:  PLoS One       Date:  2020-04-07       Impact factor: 3.240

Review 10.  Decolonising global health: transnational research partnerships under the spotlight.

Authors:  David S Lawrence; Lioba A Hirsch
Journal:  Int Health       Date:  2020-11-09       Impact factor: 2.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.